勘误：T淋巴细胞：肺癌中的关键角色。
Corrigendum: T lymphocyte cell: A pivotal player in lung cancer.
作者信息
Wu Yanan, Yuan Meng, Wang Chenlin, Chen Yanfei, Zhang Yan, Zhang Jiandong
机构信息
Department of Oncology, the First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, China.
Department of Oncology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China.
出版信息
Front Immunol. 2023 Feb 21;14:1166352. doi: 10.3389/fimmu.2023.1166352. eCollection 2023.
Abstract
[This corrects the article DOI: 10.3389/fimmu.2023.1102778.].
摘要
[本文更正了文章的数字对象标识符：10.3389/fimmu.2023.1102778。]
相似文献
1
Corrigendum: T lymphocyte cell: A pivotal player in lung cancer.勘误：T淋巴细胞：肺癌中的关键角色。
Front Immunol. 2023 Feb 21;14:1166352. doi: 10.3389/fimmu.2023.1166352. eCollection 2023.
2
Corrigendum: Characterizing the Role of Monocytes in T Cell Cancer Immunotherapy Using a 3D Microfluidic Model.勘误：使用3D微流控模型表征单核细胞在T细胞癌症免疫治疗中的作用。
Front Immunol. 2018 Jul 24;9:1719. doi: 10.3389/fimmu.2018.01719. eCollection 2018.
3
Corrigendum: TMEM123 a key player in immune surveillance of colorectal cancer.勘误：跨膜蛋白123（TMEM123）在结直肠癌免疫监视中的关键作用。
Front Immunol. 2023 Jul 28;14:1256713. doi: 10.3389/fimmu.2023.1256713. eCollection 2023.
4
Corrigendum: Peripheral blood lymphocyte subsets predict the efficacy of immune checkpoint inhibitors in non- small cell lung cancer.勘误：外周血淋巴细胞亚群可预测免疫检查点抑制剂在非小细胞肺癌中的疗效。
Front Immunol. 2022 Dec 8;13:1111230. doi: 10.3389/fimmu.2022.1111230. eCollection 2022.
5
Corrigendum: Modulation of natural killer cell exhaustion in the lungs: the key components from lung microenvironment and lung tumor microenvironment.勘误：肺中自然杀伤细胞耗竭的调节：来自肺微环境和肺肿瘤微环境的关键成分
Front Immunol. 2024 Jul 30;15:1467723. doi: 10.3389/fimmu.2024.1467723. eCollection 2024.
6
T lymphocyte cell: A pivotal player in lung cancer.T 淋巴细胞：肺癌的关键参与者。
Front Immunol. 2023 Jan 27;14:1102778. doi: 10.3389/fimmu.2023.1102778. eCollection 2023.
7
Corrigendum: Reprogramming the immunosuppressive tumor microenvironment: exploiting angiogenesis and thrombosis to enhance immunotherapy.勘误：重编程免疫抑制性肿瘤微环境：利用血管生成和血栓形成增强免疫治疗。
Front Immunol. 2023 Jul 13;14:1252998. doi: 10.3389/fimmu.2023.1252998. eCollection 2023.
8
Corrigendum: Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy.勘误：一种用于预测甲状腺癌预后和免疫治疗的新型衰老相关生物标志物的鉴定与验证
Front Immunol. 2023 Jun 5;14:1229541. doi: 10.3389/fimmu.2023.1229541. eCollection 2023.
9
Corrigendum: Tumor-Associated Macrophages in Tumor Immunity.勘误：肿瘤免疫中的肿瘤相关巨噬细胞。
Front Immunol. 2021 Dec 10;12:775758. doi: 10.3389/fimmu.2021.775758. eCollection 2021.
10
Corrigendum: Immunoglobulins and serum proteins impair anti-tumor NK cell effector functions in malignant ascites.勘误：免疫球蛋白和血清蛋白损害恶性腹水中抗肿瘤自然杀伤细胞效应功能。
Front Immunol. 2024 Apr 29;15:1420991. doi: 10.3389/fimmu.2024.1420991. eCollection 2024.
Zotero 插件